[PDF][PDF] Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization
The emergence of SARS-CoV-2 variants has raised concerns about altered sensitivity to
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
[HTML][HTML] Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization
P Wang, RG Casner, MS Nair, M Wang, J Yu… - Cell Host & Microbe, 2021 - cell.com
The emergence of SARS-CoV-2 variants has raised concerns about altered sensitivity to
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
[PDF][PDF] Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization
P Wang, RG Casner, MS Nair, Y Huang, L Shapiro… - researchgate.net
The emergence of SARS-CoV-2 variants has raised concerns about altered sensitivity to
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
[引用][C] Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization
P Wang, RG Casner, MS Nair, M Wang, J Yu… - Cell Host & …, 2021 - cir.nii.ac.jp
[PDF][PDF] Increased Resistance of SARS-CoV-2 Variants B. 1.351 and B. 1.1. 7 to Antibody Neutralization
P Wang, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu… - pdfs.semanticscholar.org
The Covid-19 pandemic has ravaged the globe, and its causative agent, SARS-CoV-2,
continues to rage. Prospects of ending this pandemic rest on the development of effective …
continues to rage. Prospects of ending this pandemic rest on the development of effective …
Increased Resistance of SARS-CoV-2 Variants B. 1.351 and B. 1.1. 7 to Antibody Neutralization
P Wang, MS Nair, L Liu, S Iketani, Y Luo, Y Guo… - 2021 - pesquisa.bvsalud.org
The COVID-19 pandemic has ravaged the globe, and its causative agent, SARS-CoV-2,
continues to rage. Prospects of ending this pandemic rest on the development of effective …
continues to rage. Prospects of ending this pandemic rest on the development of effective …
[HTML][HTML] Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization
P Wang, RG Casner, MS Nair, M Wang, J Yu… - Cell Host & …, 2021 - ncbi.nlm.nih.gov
The emergence of SARS-CoV-2 variants has raised concerns about altered sensitivity to
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
[PDF][PDF] Increased Resistance of SARS-CoV-2 Variants B. 1.351 and B. 1.1. 7 to Antibody Neutralization
P Wang, L Liu, S Iketani, Y Luo, Y Guo, M Wang, J Yu… - scienceopen.com
The Covid-19 pandemic has ravaged the globe, and its causative agent, SARS-CoV-2,
continues to rage. Prospects of ending this pandemic rest on the development of effective …
continues to rage. Prospects of ending this pandemic rest on the development of effective …
[HTML][HTML] Increased resistance of SARS-CoV-2 variant P. 1 to antibody neutralization
P Wang, RG Casner, MS Nair, M Wang, J Yu… - Cell Host & Microbe, 2021 - Elsevier
The emergence of SARS-CoV-2 variants has raised concerns about altered sensitivity to
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
antibody-mediated immunity. The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and …
[HTML][HTML] Increased Resistance of SARS-CoV-2 Variant P. 1 to Antibody Neutralization
P Wang, RG Casner, MS Nair, M Wang, J Yu, G Cerutti… - 2021 - europepmc.org
The relative resistance of SARS-CoV-2 variants B. 1.1. 7 and B. 1.351 to antibody
neutralization has been described recently. We now report that another emergent variant …
neutralization has been described recently. We now report that another emergent variant …